Amethyst Consulting and Treatment Solutions

Amethyst Consulting and Treatment Solutions, based in Columbia, MD, is one of the SAMHSA-registered treatment programs operating in MD. The facility offers a continuum of care across multiple levels — Detox, IOP, MAT — which means it can, in principle, hold a patient across the arc of a typical treatment episode. What this page can help with is the frame — what to ask, what to verify, what to compare against.

Care levels at Amethyst Consulting and Treatment Solutions

On care levels specifically: The facility offers a continuum of care across multiple levels — Detox, IOP, MAT — which means it can, in principle, hold a patient across the arc of a typical treatment episode. The practical question is whether it is genuinely strong at each level, or whether one level is the core business and the others are secondary. What that means in practice is that matching Amethyst Consulting and Treatment Solutions to the right clinical situation depends on whether you or a loved one needs the level of care this facility actually offers — which is a clinician's judgment, not a facility's sales pitch.

Insurance and payment

On insurance specifically: Amethyst Consulting and Treatment Solutions accepts Medicaid — which is consequential because facilities that accept Medicaid tend to have the broadest patient populations and the most developed public-sector relationships, though reimbursement structures mean program intensity sometimes differs from commercial-focused centers. Before admission, ask the facility's utilization-review team for a written Verification of Benefits — not verbal assurance, which is where most post-treatment financial surprises come from. Also ask for specific plan-level confirmation, not carrier-level (e.g., "your Aetna PPO plan" not just "Aetna").

Before you call

Three questions to put to Amethyst Consulting and Treatment Solutions before admission: the specific ASAM level the facility is billing; the written Verification of Benefits for your specific plan product; the MAT policy (continuation of buprenorphine or methadone during residential, specifically). The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation. Getting answers in writing protects against the downstream surprises.